‘Highly concerning’: Hydrocortisone manufacturers' £100m fine overturned
Manufacturers that hiked hydrocortisone prices by 10,000% and paid off competitors will not have to pay “nearly £100m of fines” after a successful appeal, the Competition Appeal Tribunal (CAT) has ruled.
